Westpac Banking Corp’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-43,895
Closed -$3.03M 463
2025
Q2
$3.03M Sell
43,895
-28,978
-40% -$1.97M 0.2% 113
2025
Q1
$5.06M Sell
72,873
-2,873
-4% -$237K 0.37% 64
2024
Q4
$6.52M Buy
75,746
+12,068
+19% +$1.31M 0.43% 47
2024
Q3
$7.58M Buy
+63,678
New +$8.49M 0.51% 42

Other funds holding NVO

Westpac Banking Corp's NVO Position: Q3 2025 in Review

Westpac Banking Corp sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 43,895 shares — an estimated $3.03M sold.

Westpac Banking Corp first reported a position in NVO in Q3 2024 and held it in 4 quarters. The position peaked at $7.58M in Q3 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Westpac Banking Corp reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Westpac Banking Corp sold 43,895 Novo Nordisk shares in Q3 2025, an estimated $3.03M.
  • Westpac Banking Corp first reported a position in Novo Nordisk in Q3 2024 and held it in 4 quarters.
  • Westpac Banking Corp's Novo Nordisk position peaked at $7.58M in Q3 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Westpac Banking Corp's 13F filing for Q3 2025, filed 12 Nov 2025.